Feeding the world is going to require the scientific and financial muscle of agricultural biotechnology companies. Natasha Gilbert asks whether they're up to the task.

An empirical study of the impact of patenting and licensing on regional manufacturing of human papilloma virus vaccines to help improve vaccine affordability and access.

The demands of global capital, mediated through the market, are increasingly driving the trajectory of advances in science. Today this acts as the principal barrier to the advance of science as a knowledge system that is designed to serve the needs of the people. The needs of a neo-liberal economic order valorises immediate gain as the principal driver of science.

A proposal to draft a plurilateral anti-counterfeiting treaty among developed countries needs global resistance. (Editorial)